Global Glioblastoma Treatment Drugs Market Report By Type (VEGF/VEGFR Inhibitor, Alkylating Agents And Miscellaneous Antineoplastic), Distribution Channel (Hospital, Cancer Research Organization, Long Term Care Center And Diagnostic Centers) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2018-2025
ID:VMR11210609
March 2019
Report Formats:

As per this study, the Global Glioblastoma Treatment Drugs Market was valued USD XX.X MN (by revenue) in 2018 and is anticipated to reach USD XX.X MN by 2025 with a CAGR of X.X%.

Glioblastoma also is known as glioblastoma multiforme, is a type of malignant brain tumor that develops from glial cells. It proliferates at a rapid rate and is difficult to cure however; the treatment drugs are often prescribed to ease the symptoms. Common symptoms are a constant headache, nausea, personality changes, blurred vision and loss of appetite. VEGF/VEGFR Inhibitors, Alkylating Agents and Miscellaneous Antineoplastic
agents are used to treat glioblastoma.

Market Dynamics
 
Rising elderly population followed by an increase in the prevalence of cancer is driving the market growth. Increased funding to the companies performing research for the development of more effective drugs is further fueling the market growth. Also, ongoing R&D in gene therapy and molecular biotechnology for treating brain and spine-related disorders is likely to push the market growth. Despite this, relatively higher expenditure for GBM treating drugs is the key challenge for the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of glioblastoma treatment drugs.
 
Market Segmentation
 
The broad glioblastoma treatment drugs market has been sub-grouped into type and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • VEGF/VEGFR Inhibitor
  • Alkylating Agents
  • Miscellaneous Antineoplastic
 
By Distribution Channel
  • Hospital
  • Cancer Research Organization
  • Long Term Care Center
  • Diagnostic Centers
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for glioblastoma treatment drugs in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Glioblastoma Treatment Drugs Market By Revenue (USD MN)
 
Europe Glioblastoma Treatment Drugs Market By Revenue
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the glioblastoma treatment drugs market include Arbor Pharms LLC., Bristol-Myers Squibb Company, Emcure Pharmaceuticals Ltd., F. Hoffmann-La Roche AG, Merck & Co., Inc., Sandoz, and Sigma-Tau Pharmaceuticals, Inc.
among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1. INTRODUCTION

  • Introduction To Glioblastoma Treatment Drugs
  • Report Description
    • Objectives Of The Study
    • Assumptions
  • Research Scope
  • Research Methodology
    • Data Source
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Glioblastoma Treatment Drugs Market: Snapshot
 
3. MARKET ANALYSIS
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
  • Value Chain Analysis
 
4. GLIOBLASTOMA TREATMENT DRUGS MARKET ANALYSIS BY TYPE
  • Market In VEGF/VEGFR Inhibitor
  • Market In Alkylating Agents
  • Market In Miscellaneous Antineoplastic
 
5. GLIOBLASTOMA TREATMENT DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
  • Market In Hospital
  • Market In Cancer Research Organization
  • Market In Long Term Care Center
  • Market In Diagnostic Centers
 
6. GLIOBLASTOMA TREATMENT DRUGS MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.) Market Estimates By Segments
    • Rest Of North America Market Estimates By Segments
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK) Market Estimates By Segments
    • Germany Market Estimates By Segments
    • France Market Estimates By Segments
    • Rest Of Europe Market Estimates By Segments
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China Market Estimates By Segments
    • Japan Market Estimates By Segments
    • India Market Estimates By Segments
    • Rest Of Asia Pacific Market Estimates By Segments  
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil Market Estimates By Segments
    • Rest Of Latin America Market Estimates By Segments
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East Market Estimates By Segments
    • Africa Market Estimates By Segments
 
7. COMPETITIVE LANDSCAPE OF THE GLIOBLASTOMA TREATMENT DRUGS COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE GLIOBLASTOMA TREATMENT DRUGS INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Arbor Pharms LLC.
  • Bristol-Myers Squibb Company
  • Emcure Pharmaceuticals Ltd.
  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc.
  • Sandoz
  • Sigma-Tau Pharmaceuticals, Inc.

 
* Tentative TOC
 
LIST OF TABLES
 
Table 1.  Market Highlights Of Glioblastoma Treatment Drugs
Table 2.  Global Glioblastoma Treatment Drugs Market By Types
Table 3.  Global Glioblastoma Treatment Drugs Market By Distribution Channel
Table 4.  Global Glioblastoma Treatment Drugs Market By Geography
Table 5.  North America Glioblastoma Treatment Drugs Market
Table 6.  Europe Glioblastoma Treatment Drugs Market
Table 7.  Asia Pacific Glioblastoma Treatment Drugs Market
Table 8.  Latin America Glioblastoma Treatment Drugs Market
Table 9.  Middle East And Africa Glioblastoma Treatment Drugs Market 
Table 10. Partnership/Collaboration/Agreements
Table 11. Mergers And Acquisitions
Table 12. New Product Development
Table 13. Other Developments
  
LIST OF FIGURES
 
Fig. 1.     Market Segmentation Of Glioblastoma Treatment Drugs Market 
Fig. 2.     Top-Down Approach   
Fig. 3.     Bottom-Up Approach   
Fig. 4.     Market Highlights Of Glioblastoma Treatment Drugs
Fig. 5.     Porter’s Five Forces Analysis
Fig. 6.     Value Chain Analysis
Fig. 7.     Global Glioblastoma Treatment Drugs Market By Types
Fig. 8.     Global Glioblastoma Treatment Drugs Market By Distribution Channel
Fig. 9.     Global Glioblastoma Treatment Drugs Market By Geography
Fig. 10.   North America Glioblastoma Treatment Drugs Market
Fig. 11.   Europe Glioblastoma Treatment Drugs Market
Fig. 12.   Asia Pacific Glioblastoma Treatment Drugs Market
Fig. 13.   Latin America Glioblastoma Treatment Drugs Market
Fig. 14.   Middle East And Africa Glioblastoma Treatment Drugs Market
Fig. 15.   Market Share Of Glioblastoma Treatment Drugs Companies
Fig. 16.   Recent Developments In Glioblastoma Treatment Drugs Industry
 
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.  

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials